WO2004064824A1 - Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments - Google Patents

Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments Download PDF

Info

Publication number
WO2004064824A1
WO2004064824A1 PCT/EP2003/014171 EP0314171W WO2004064824A1 WO 2004064824 A1 WO2004064824 A1 WO 2004064824A1 EP 0314171 W EP0314171 W EP 0314171W WO 2004064824 A1 WO2004064824 A1 WO 2004064824A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
group
phenyl
hydrogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/014171
Other languages
English (en)
French (fr)
Inventor
Flavio Leoni
Paolo Mascagni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Priority to US10/542,244 priority Critical patent/US8227515B2/en
Priority to DE60311888T priority patent/DE60311888T2/de
Priority to JP2004566776A priority patent/JP4495599B2/ja
Priority to AU2003290034A priority patent/AU2003290034A1/en
Priority to EP03782390A priority patent/EP1583523B1/en
Publication of WO2004064824A1 publication Critical patent/WO2004064824A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/EP2003/014171 2003-01-17 2003-12-10 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments Ceased WO2004064824A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/542,244 US8227515B2 (en) 2003-01-17 2003-12-10 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments
DE60311888T DE60311888T2 (de) 2003-01-17 2003-12-10 Verwendung von hydroxamsäurederivaten zur herstellung von antitumorarzneimitteln
JP2004566776A JP4495599B2 (ja) 2003-01-17 2003-12-10 抗腫瘍薬の調製のためにヒドロキサム酸誘導体を使用する方法
AU2003290034A AU2003290034A1 (en) 2003-01-17 2003-12-10 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments
EP03782390A EP1583523B1 (en) 2003-01-17 2003-12-10 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000064A ITMI20030064A1 (it) 2003-01-17 2003-01-17 Uso dei derivati dell'acido idrossamico per la preparazione
ITMI2003A000064 2003-01-17

Publications (1)

Publication Number Publication Date
WO2004064824A1 true WO2004064824A1 (en) 2004-08-05

Family

ID=32750476

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/014171 Ceased WO2004064824A1 (en) 2003-01-17 2003-12-10 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments

Country Status (8)

Country Link
US (1) US8227515B2 (https=)
EP (1) EP1583523B1 (https=)
JP (1) JP4495599B2 (https=)
AU (1) AU2003290034A1 (https=)
DE (1) DE60311888T2 (https=)
ES (1) ES2282705T3 (https=)
IT (1) ITMI20030064A1 (https=)
WO (1) WO2004064824A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2344253B1 (en) * 2008-09-29 2014-04-23 Italfarmaco SpA Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0901465A1 (en) * 1996-05-14 1999-03-17 ITALFARMACO S.p.A. Compounds with anti-inflammatory and immunosuppressive activities
WO2001038322A1 (en) * 1999-11-23 2001-05-31 Methylgene, Inc. Inhibitors of histone deacetylase
WO2002074298A1 (en) * 2001-03-21 2002-09-26 Ono Pharmaceutical Co., Ltd. Il-6 production inhibitors
WO2003013493A1 (en) * 2001-08-07 2003-02-20 Italfarmaco S.P.A. Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
WO2003070691A1 (en) * 2002-02-21 2003-08-28 Osaka Industrial Promotion Organization N-hydroxycarboxamide derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101257D0 (sv) * 2001-04-06 2001-04-06 A & Science Invest Ab Treatment of whiplash associated disorder

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0901465A1 (en) * 1996-05-14 1999-03-17 ITALFARMACO S.p.A. Compounds with anti-inflammatory and immunosuppressive activities
WO2001038322A1 (en) * 1999-11-23 2001-05-31 Methylgene, Inc. Inhibitors of histone deacetylase
WO2002074298A1 (en) * 2001-03-21 2002-09-26 Ono Pharmaceutical Co., Ltd. Il-6 production inhibitors
WO2003013493A1 (en) * 2001-08-07 2003-02-20 Italfarmaco S.P.A. Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
WO2003070691A1 (en) * 2002-02-21 2003-08-28 Osaka Industrial Promotion Organization N-hydroxycarboxamide derivative

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; NAKA, MASAO ET AL: "Preparation of N-acylaminoalkanehydroxamic acids as IL-6 production inhibitors", XP002276409, retrieved from STN Database accession no. 137:247516 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; UESATO, SHINICHI ET AL: "Preparation of N-hydroxycarboxamide derivatives as anticancer agents", XP002276410, retrieved from STN Database accession no. 139:214215 *
JUNG, MANFRED ET AL: "Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase an Inducers of Terminal Cell Differentiation", JOURNAL OF MEDICINAL CHEMISTRY (1999), 42(22), 4669-4679, XP002144226 *
NICOLAUS B J R: "Symbiotic Approach to Drug Design", DECISION MAKING IN DRUG RESEARCH, XX, XX, 1983, pages 173 - 186, XP002197412 *
UESATO, SHINICHI ET AL: "Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002), 12(10), 1347-1349, XP002276408 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2344253B1 (en) * 2008-09-29 2014-04-23 Italfarmaco SpA Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes

Also Published As

Publication number Publication date
DE60311888D1 (de) 2007-03-29
EP1583523B1 (en) 2007-02-14
EP1583523A1 (en) 2005-10-12
AU2003290034A1 (en) 2004-08-13
US20060063800A1 (en) 2006-03-23
DE60311888T2 (de) 2007-12-06
JP2006514659A (ja) 2006-05-11
JP4495599B2 (ja) 2010-07-07
ES2282705T3 (es) 2007-10-16
US8227515B2 (en) 2012-07-24
ITMI20030064A1 (it) 2004-07-18

Similar Documents

Publication Publication Date Title
US5798339A (en) Treatment method for cancer
JP2001519366A (ja) ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法
KR890701562A (ko) 면역조절 아자스 피란류
NL8204126A (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met locaal-anesthetische werking dat een dialylamino-2',6'acetoxylidide en/of een farmaceutisch aanvaardbaar zout daarvan bevat, alsmede de onder toepassing van deze werkwijze verkregen gevormde farmaceutische preparaten en werkwijze voor het bereiden van dialkylamino-2',6'acetoxylididen en de farmaceutisch aanvaardbare zouten daarvan.
US6362207B1 (en) Methods of treating viral infections with benzimidazoles
WO1989007441A1 (en) 6-amino-1,2-benzopyrone antitumorigenic agents and method
EP3378473A1 (en) Drug combination having anti-tumor efficacy
US5750515A (en) Cancer metastasis inhibitor
US8227515B2 (en) Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments
CA2071819A1 (en) Antitumor potentiator and antitumor composition
JP2009525987A (ja) 黒色腫の治療のためのガリウム（ｉｉｉ）錯体の使用
Seelig et al. Efficacy of dinaline and its methyl and acetyl derivatives against colorectal cancer in vivo and in vitro
US5534513A (en) Antitumor potentiator and antitumor composition
EP0418327B1 (en) Antiemesis ergoline derivatives
WO1994008584A1 (fr) Inhibiteur de la metastase d'une tumeur maligne
JP2005511659A5 (https=)
PT1385513E (pt) Associações farmacêuticas à base de derivados de piridoindolona e agentes anticancerígenos
GB2076395A (en) Nonaprenylamine derivatives
Ludden et al. Antihypertensive activity of some novel pyridinylidene arylurea derivatives in spontaneously hypertensive rats
JPS61129124A (ja) 抗腫瘍剤
WO1992000740A2 (en) Bis-dioxopiperazines and their use as protection agents
JPS6257165B2 (https=)
JPS6213924B2 (https=)
JPS61129128A (ja) 抗腫瘍剤
EP2258370A1 (en) Treatment of malignant diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003782390

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006063800

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10542244

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004566776

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2003782390

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10542244

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2003782390

Country of ref document: EP